This is a monocenter, open-label, uncontrolled study in accordance with §23b MPG to evaluate
the efficacy of the HIFU-treatment of fibroadenoma using the TH-One device.
Device: High Intensity Focused Ultrasound
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT03022695
Ages eligible for Study
18 Years and older
Genders eligible for Study
Accepts Healthy Volunteers
Female patients 18 years or older with at least one diagnosed breast fibroadenoma. Diagnosis of fibroadenoma must be based on:
women ≤ 40 years of age: ultrasound image alone; women > 40 years of age: ultrasound image and mammogram,
histological confirmation of fibroadenoma of the breast. Patient's fibroadenoma size as determined by ultrasound imaging: the longest diameter is limited to 25 mm. Women of childbearing potential must have a negative urine pregnancy test within 72 hours prior to HIFU treatment. Patient must be able to understand the nature and the extent of the study and the procedures required and be willing and able to complete the screening and study procedures. Patient must give written informed consent (personally signed and dated) before completing any study-related procedure.
Patient who is pregnant or breast-feeding.
Patient with history of ipsilateral breast cancer within 5 years prior to study inclusion or radio therapy to the target breast within 5 years prior to study inclusion.
Patient with implant on the treated breast.
Patient with target fibroadenoma pre-treated by cryoablation or interstitial laser therapy within 12 month before recruiting for HIFU.
Patient's fibroadenoma not clearly visible on the ultrasound images (in B mode) at the inclusion visit. Patient participating in other studies using drugs or medical devices within 3 months prior to study inclusion or during study participation including the follow-up period.
All locations for NCT03022695
Department for Women's Health
Tübingen, Germany, 72076
View full eligibility
Tris trial is registered with FDA with number: NCT03022695. The sponsor of the trial is University Women's Hospital Tübingen and it is looking for 27 volunteers for the current phase.
Official trial title: Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.